Background: We examined whether development of radiation-induced lung injury after irradiation for breast cancer correlates with lymphocyte radiosensitivity (LRS) in vitro.
Materials and methods: Patients were selected from a cohort of 177 patients, who were treated with adjuvant postoperative radiotherapy (RT) for loco-regional breast cancer, and included 14 patients who had severe early lung injury measured as respiratory symptoms caused by RT and treated with corticosteroids (i.e. "cases") and a corresponding 14 control patients without such symptoms. LRS was measured as the postirradiation fraction of mitogen-stimulated blood lymphocytes in S- and G2-phase. Plasma levels of TGF-beta 1 and thiols, both suggested to be involved in the pathogenesis of radiation-induced lung injury, were also analysed.
Results: The result showed that cells from the controls responded to a higher extent to mitogen stimulation than cells from the cases (p < 0.05). Analysis of the fraction of S- and G2-phase cells after irradiation showed no significant difference between the two groups (p = 0.57 and 0.31, respectively). There was no difference in plasma levels of TGF-beta 1 and thiols in patients who did or did not develop pulmonary injury after RT. Tamoxifen administered before or at RT did not influence the incidence of pulmonary reactions.
Conclusion: No differences in LRS were found between breast cancer patients with lung complications after RT and matched control patients without complications.